Suppr超能文献

鉴定与其他季节性冠状病毒具有同源性的 SARS-CoV-2 的新型候选 CD8+T 细胞表位。

Identification of Novel Candidate CD8 T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses.

机构信息

Centre for Dengue Research, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda 10250, Sri Lanka.

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX1 4BH, UK.

出版信息

Viruses. 2021 May 24;13(6):972. doi: 10.3390/v13060972.

Abstract

Cross-reactive T cell immunity to seasonal coronaviruses (HCoVs) may lead to immunopathology or protection during SARS-CoV2 infection. To understand the influence of cross-reactive T cell responses, we used IEDB (Immune epitope database) and NetMHCpan (ver. 4.1) to identify candidate CD8 T cell epitopes, restricted through HLA-A and B alleles. Conservation analysis was carried out for these epitopes with HCoVs, OC43, HKU1, and NL63. 12/18 the candidate CD8 T cell epitopes (binding score of ≥0.90), which had a high degree of homology (>75%) with the other three HCoVs were within the NSP12 and NSP13 proteins. They were predicted to be restricted through HLA-A2402, HLA-A201, HLA-A206, and HLA-B alleles B3501. Thirty-one candidate CD8 T cell epitopes that were specific to SARS-CoV2 virus (<25% homology with other HCoVs) were predominantly identified within the structural proteins (spike, envelop, membrane, and nucleocapsid) and the NSP1, NSP2, and NSP3. They were predominantly restricted through HLA-B3501 (6/31), HLA-B4001 (6/31), HLA-B4403 (7/31), and HLA-A2402 (8/31). It would be crucial to understand T cell responses that associate with protection, and the differences in the functionality and phenotype of epitope specific T cell responses, presented through different HLA alleles common in different geographical groups, to understand disease pathogenesis.

摘要

针对季节性冠状病毒(HCoV)的交叉反应性 T 细胞免疫可能导致 SARS-CoV2 感染期间的免疫病理或保护。为了了解交叉反应性 T 细胞反应的影响,我们使用 IEDB(免疫表位数据库)和 NetMHCpan(版本 4.1)来鉴定受 HLA-A 和 B 等位基因限制的候选 CD8 T 细胞表位。对这些表位与 HCoV、OC43、HKU1 和 NL63 进行了保守性分析。共有 12/18 候选 CD8 T 细胞表位(结合评分≥0.90)与其他三种 HCoV 具有高度同源性(>75%),位于 NSP12 和 NSP13 蛋白内。它们被预测受 HLA-A2402、HLA-A201、HLA-A206 和 HLA-B 等位基因 B3501 限制。31 个候选 SARS-CoV2 病毒特异性 CD8 T 细胞表位(与其他 HCoV 的同源性<25%)主要位于结构蛋白(刺突、包膜、膜和核衣壳)和 NSP1、NSP2 和 NSP3 内。它们主要受 HLA-B3501(6/31)、HLA-B4001(6/31)、HLA-B4403(7/31)和 HLA-A2402(8/31)限制。了解与保护相关的 T 细胞反应以及不同 HLA 等位基因普遍存在于不同地理群体中,从而了解疾病发病机制的不同功能和表型的表位特异性 T 细胞反应之间的差异非常重要。

相似文献

4
SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
Front Immunol. 2021 Apr 28;12:627568. doi: 10.3389/fimmu.2021.627568. eCollection 2021.
6
CD8 T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2.
Front Immunol. 2022 Jan 18;12:764949. doi: 10.3389/fimmu.2021.764949. eCollection 2021.
7
Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?
Virus Res. 2021 Nov;305:198579. doi: 10.1016/j.virusres.2021.198579. Epub 2021 Sep 21.
8
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Microbiol Spectr. 2022 Feb 23;10(1):e0278021. doi: 10.1128/spectrum.02780-21.
10
COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Hum Vaccin Immunother. 2021 Apr 3;17(4):1097-1108. doi: 10.1080/21645515.2020.1823777. Epub 2020 Nov 11.

引用本文的文献

1
New Short RNA Motifs Potentially Relevant in the SARS-CoV-2 Genome.
Curr Genomics. 2023 Feb 14;23(6):424-440. doi: 10.2174/1389202924666230202152351.
4
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Microbiol Spectr. 2022 Feb 23;10(1):e0278021. doi: 10.1128/spectrum.02780-21.

本文引用的文献

1
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
Immunity. 2020 Dec 15;53(6):1245-1257.e5. doi: 10.1016/j.immuni.2020.11.004. Epub 2020 Nov 13.
2
Characterization of pre-existing and induced SARS-CoV-2-specific CD8 T cells.
Nat Med. 2021 Jan;27(1):78-85. doi: 10.1038/s41591-020-01143-2. Epub 2020 Nov 12.
3
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Science. 2020 Dec 11;370(6522):1339-1343. doi: 10.1126/science.abe1107. Epub 2020 Nov 6.
4
Explaining among-country variation in COVID-19 case fatality rate.
Sci Rep. 2020 Nov 3;10(1):18909. doi: 10.1038/s41598-020-75848-2.
5
Unbiased Screens Show CD8 T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.
Immunity. 2020 Nov 17;53(5):1095-1107.e3. doi: 10.1016/j.immuni.2020.10.006. Epub 2020 Oct 20.
6
Association between HLA gene polymorphisms and mortality of COVID-19: An in silico analysis.
Immun Inflamm Dis. 2020 Dec;8(4):684-694. doi: 10.1002/iid3.358. Epub 2020 Oct 13.
7
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
Front Immunol. 2020 Sep 3;11:2008. doi: 10.3389/fimmu.2020.02008. eCollection 2020.
8
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30.
9
Suboptimal SARS-CoV-2-specific CD8 T cell response associated with the prominent HLA-A*02:01 phenotype.
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24384-24391. doi: 10.1073/pnas.2015486117. Epub 2020 Sep 10.
10
Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
Nat Immunol. 2020 Nov;21(11):1336-1345. doi: 10.1038/s41590-020-0782-6. Epub 2020 Sep 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验